Angiotensin and Bradykinin: Targets for the Treatment of Vascular and Neuro-Glial Pathology in Diabetic Retinopathy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-10 ,pp. : 3313-3330

Bentham Science Publishers

Access to resources Recommend Favorite

Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss

By  

Current Neuropharmacology, Vol. 14, Iss. 8, 2016-11 ,pp. : 831-839

Bentham Science Publishers

Access to resources Recommend Favorite

Ruboxistaurin: reduced progression of diabetic retinopathy?

By  

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Advanced Glycation and Advanced Lipoxidation: Possible Role in Initiation and Progression of Diabetic Retinopathy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-10 ,pp. : 3349-3360

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria Damage in the Pathogenesis of Diabetic Retinopathy and in the Metabolic Memory Associated with its Continued Progression

By  

Current Medicinal Chemistry, Vol. 20, Iss. 26, 2013-09 ,pp. : 3226-3233

Bentham Science Publishers

Access to resources Recommend Favorite